FAR-IT

Main information

  • Trade name:
  • FAR-IT - CAP
  • Dosage:
  • 20,150;MG
  • Pharmaceutical form:
  • CAP
  • Composition:
  • -
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FAR-IT - CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

15-8-2016

An impact on the European agenda

An impact on the European agenda

In five short videos, we describe how we work with safety for Danish medicine users at the Danish Medicines Agency. The work extends far beyond the borders of Denmark when we assess whether to authorise new medicines and whether the side effects of a medicine are too serious in relation to its efficacy.

Danish Medicines Agency

22-2-2012

Changed criteria for single reimbursement for osteoporosis medicines other than alendronate

Changed criteria for single reimbursement for osteoporosis medicines other than alendronate

As of 5 March 2012, it will only be possible to obtain a single reimbursement grant for the other medicines used in osteoporosis treatment for patients that cannot use alendronate. The criteria for single reimbursement are changed because of the large price gaps between the different medicines, where the reimbursement price of alendronate is by far the lowest.

Danish Medicines Agency

23-4-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [REMEDYREPACK INC.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [REMEDYREPACK INC.]

Updated Date: Apr 23, 2018 EST

US - DailyMed

16-4-2018

ACIPHEX (Rabeprazole Sodium) Tablet, Delayed Release [Eisai Inc.]

ACIPHEX (Rabeprazole Sodium) Tablet, Delayed Release [Eisai Inc.]

Updated Date: Apr 16, 2018 EST

US - DailyMed

10-4-2018

RABEPRAZOLE SODIUM (Rabeprazole) Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

RABEPRAZOLE SODIUM (Rabeprazole) Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

Updated Date: Apr 10, 2018 EST

US - DailyMed

4-4-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [Lupin Pharmaceuticals, Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Lupin Pharmaceuticals, Inc.]

Updated Date: Apr 4, 2018 EST

US - DailyMed

30-3-2018

Stroke's Impact May Go Far Beyond the Physical, Study Finds

Stroke's Impact May Go Far Beyond the Physical, Study Finds

Title: Stroke's Impact May Go Far Beyond the Physical, Study FindsCategory: Health NewsCreated: 3/28/2018 12:00:00 AMLast Editorial Review: 3/29/2018 12:00:00 AM

US - MedicineNet

26-3-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [NuCare Pharmaceuticals,Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [NuCare Pharmaceuticals,Inc.]

Updated Date: Mar 26, 2018 EST

US - DailyMed

7-3-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [Aurobindo Pharma Limited]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Aurobindo Pharma Limited]

Updated Date: Mar 7, 2018 EST

US - DailyMed

6-2-2018

Protonix vs. Aciphex

Protonix vs. Aciphex

Protonix (pantoprazole sodium) and Aciphex (rabeprazole sodium) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. Aciphex is also used to treat duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori (H. pylori) bacterial infections in the stomach.

US - RxList

5-2-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [Torrent Pharmaceuticals Limited]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Torrent Pharmaceuticals Limited]

Updated Date: Feb 5, 2018 EST

US - DailyMed

30-1-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [AvKARE, Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [AvKARE, Inc.]

Updated Date: Jan 30, 2018 EST

US - DailyMed

19-1-2018

Rabeprazole

Rabeprazole

Rabeprazole is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori (H. pylori) bacterial infections in the stomach.

US - RxList

10-1-2018

RABEPRAZOLE SODIUM Tablet, Delayed Release [Proficient Rx LP]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Proficient Rx LP]

Updated Date: Jan 10, 2018 EST

US - DailyMed

29-12-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [Bryant Ranch Prepack]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Bryant Ranch Prepack]

Updated Date: Dec 29, 2017 EST

US - DailyMed

11-12-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [Breckenridge Pharmaceutical, Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Breckenridge Pharmaceutical, Inc.]

Updated Date: Dec 11, 2017 EST

US - DailyMed

11-12-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [A-S Medication Solutions]

RABEPRAZOLE SODIUM Tablet, Delayed Release [A-S Medication Solutions]

Updated Date: Dec 11, 2017 EST

US - DailyMed

4-12-2017

RABEPRAZOLE SODIUM (Rabeprazole) Tablet, Delayed Release [Proficient Rx LP]

RABEPRAZOLE SODIUM (Rabeprazole) Tablet, Delayed Release [Proficient Rx LP]

Updated Date: Dec 4, 2017 EST

US - DailyMed

29-11-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals Inc.]

Updated Date: Nov 29, 2017 EST

US - DailyMed

21-11-2017

MI Linked to Increased Vascular Dementia, Not Alzheimer's

MI Linked to Increased Vascular Dementia, Not Alzheimer's

A history of MI is associated with an increased risk of vascular dementia by as much as 35%, with the higher risk extending as far as 35 years after the event, results of a population-based study suggest[1].

US - RxList

3-7-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [Unit Dose Services]

RABEPRAZOLE SODIUM Tablet, Delayed Release [Unit Dose Services]

Updated Date: Jul 3, 2017 EST

US - DailyMed

25-5-2017

RABEPRAZOLE SODIUM Tablet, Delayed Release [NuCare Pharmaceuticals, Inc.]

RABEPRAZOLE SODIUM Tablet, Delayed Release [NuCare Pharmaceuticals, Inc.]

Updated Date: May 25, 2017 EST

US - DailyMed